Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 4.

Kim, Youn H; Bagot, Martine; Pinter-Brown, Lauren; et al; MAVORIC Investigators (2018). Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial. Lancet Oncology, 19(9):1192-1204.

Trautinger, Franz; Eder, Johanna; Assaf, Chalid; Bagot, Martine; Cozzio, Antonio; Dummer, Reinhard; Gniadecki, Robert; Klemke, Claus-Detlev; Ortiz-Romero, Pablo L; Papadavid, Evangelia; Pimpinelli, Nicola; Quaglino, Pietro; Ranki, Annamari; Scarisbrick, Julia; Stadler, Rudolf; Väkevä, Liisa; Vermeer, Maarten H; Whittaker, Sean; Willemze, Rein; Knobler, Robert (2017). European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017. European Journal of Cancer, 77:57-74.

Goldinger, Simone M; Gobbi Bischof, Sharon; Fink-Puches, Regina; Klemke, Claus-Detlev; Dréno, Brigitte; Bagot, Martine; Dummer, Reinhard (2016). Efficacy and safety of Apo866 in patients with refractory or relapsed cutaneous t-cell lymphoma: a phase 2 clinical trial. JAMA Dermatology, 152(7):837-839.

Dummer, Reinhard; Quaglino, Pietro; Becker, Jürgen C; Hasan, Baktiar; Karrasch, Matthias; Whittaker, Sean; Morris, Stephen; Weichenthal, Michael; Stadler, Rudolf; Bagot, Martine; Cozzio, Antonio; Bernengo, Maria G; Knobler, Robert (2012). Prospective international multicenter phase II trial of intravenous pegylated liposomal doxorubicin monochemotherapy in patients with stage IIB, IVA, or IVB advanced mycosis fungoides: final results from EORTC 21012. Journal of Clinical Oncology, 30(33):4091-4097.

This list was generated on Tue Oct 16 18:21:02 2018 CEST.